500 Triple blockade with LEE011, everolimus, and exemestane in women with ER+/HER2− advanced/metastatic breast cancer: results from a Phase Ib clinical trial
Title:
500 Triple blockade with LEE011, everolimus, and exemestane in women with ER+/HER2− advanced/metastatic breast cancer: results from a Phase Ib clinical trial
Author:
Bardia, A. Chavez-MacGregor, C. Modi, S. Campone, M. Ma, B. Kittaneh, M. Dirix, L. Motta, M. Zhang, V. Bhansali, S. Fjaellskog, M.L. Oliveira, M.